In Vitro Skin Penetration of 5α-Reductase Inhibitors from Tectona Grandis Leaf Extracts

    March 2025 in “ Molecules ”
    Kamonlak Insumrong, Neti Waranuch, Kornkanok Ingkaninan, Nutchaninad Tanuphol, Abhay Prakash Mishra, Wudtichai Wisuitiprot, Eakkaluk Wongwad, Ngamrayu Ngamdokmai, Nungruthai Suphrom
    TLDR Tectona grandis leaf extracts, especially with propylene glycol, may be promising for topical hair loss treatments.
    The study examined the in vitro skin penetration of two 5α-reductase inhibitors from Tectona grandis leaf extracts, focusing on their potential for hair loss treatments. Using the Franz diffusion cell model, it was found that compound 1 had significantly higher skin penetration than compound 2, attributed to its greater hydrophobicity. Both compounds showed poor solubility in water but improved solubility in HEPES buffer with 2% Tween 20, and their penetration was enhanced by propylene glycol (PG). After 24 hours, compound 1 achieved a penetration of 12.72% in PG, while compound 2 reached 11.30%. These findings suggest that T. grandis extracts, especially with PG, could be promising for developing topical hair loss treatments.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 177 results
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 1 year ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community NW5 at 19. How many grafts do I need?

      in Transplants  142 upvotes 2 years ago
      A 19-year-old with rapid hair loss since 16 is considering a hair transplant but refuses to take finasteride or any 5α-Reductase inhibitors. They are currently using minoxidil, tretinoin, and microneedling with a Derminator 2, and only want hair until age 27.
      Can I still save my hairline at age of 15?

      community Can I still save my hairline at age of 15?

      in General  532 upvotes 3 months ago
      A 15-year-old is concerned about hair loss, possibly at Norwood 2 or 3, and is using shampoos and conditioners recommended by a trichologist. Suggestions include considering topical minoxidil and consulting a doctor about topical anti-DHT treatments like finasteride or RU58841, but avoiding 5-alpha-reductase inhibitors at this age.

      community Massive study on finasteride side effects released

      in Finasteride/Dutasteride  83 upvotes 3 years ago
      The release of a study on 5a-reductase inhibitors (finasteride and dutasteride) which showed an increased risk of depression, dementia, decreased libido, and reduced semen load as potential side effects; discussion around other forms of hair loss treatments such as topical minoxidil, RU58841, or opting to accept baldness; and advice to consider professional help for deeper issues related to hair loss.

    Similar Research

    5 / 1000+ results